Single peptide Vial strength 10 mg
Melanotan II10 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Melanotan II, explained simply
A synthetic alpha-MSH analogue studied for skin pigmentation and other effects mediated by melanocortin receptors.
Research area
Pigmentation and sexual-function signalling
How it works
Activation of melanocortin receptors, including MC1R and MC4R, is associated with pigmentation and different central responses respectively.
Why it matters
The same molecule is discussed for different outcomes, so skin effects should be separated from other observed effects.
What has been observed
Early human pigmentation studies also reported nausea and flushing among adverse effects.
Effects and points to consider
Early studies do not define safety for unsupervised or prolonged use. Pigmentation does not replace UV protection.
01 / Vial strength 10 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 10 mg Melanotan II |
|---|---|
| Final volume | 3 mL |
| Concentration | 3.33 mg/mL |
| One U-100 unit | 33.33 mcg in 0.01 mL |
Standard / Gradual Titration (3 mL = 3.33 mg/mL)
| Week / Phase | Daily Dose | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 250 mcg (0.25 mg) | 7.5 units (0.075 mL) |
| Week 2 | 500 mcg (0.5 mg) | 15 units (0.15 mL) |
| Week 3 | 750 mcg (0.75 mg) | 22.5 units (0.225 mL) |
| Weeks 4–8 | 1000 mcg (1 mg) | 30 units (0.30 mL) |
| Maintenance (after Week 8) | 500–1000 mcg (1–2× weekly) | 15–30 units (0.15–0.30 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.